Recombinant Cytokeratin 13 anticorps
Aperçu rapide pour Recombinant Cytokeratin 13 anticorps (ABIN5557438)
Antigène
Voir toutes Cytokeratin 13 (KRT13) AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
-
-
Fonction
- Cytokeratin 13 Recombinant Antibody
-
Réactivité croisée
- Humain, Souris
-
Purification
- Purified by Protein A.
-
Immunogène
- A synthesized peptide derived from human Cytokeratin 13
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB(1:200-400), IHC-P(1:100-500), IHC-F(1:50-200), IF(), ICC/IF(1:50-100)
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
-
Date de péremption
- 12 months
-
-
- Cytokeratin 13 (KRT13) (Keratin 13 (KRT13))
-
Autre désignation
- Cytokeratin 13
-
Sujet
- Synonyms: type I cytoskeletal 13, 47 kDa cytokeratin, CK-13, CK13, Cytokeratin-13, K13, K1C13_HUMAN, Ka13, Keratin 13, Keratin, keratin type I cytoskeletal 13, Keratin-13, Krt-1.13, Krt1-13, KRT13, MGC161462, MGC3781, Type I keratin Ka13, Keratin, type I cytoskeletal 13, K13.
-
ID gène
- 3861
-
UniProt
- P02533
Antigène
-